Darling Ingredients plans $67.5K stock sale

Darling Ingredients Inc. filed a notice of proposed sale of 1,000 shares of Common Stock through Citigroup Global Markets on the NYSE, with an aggregate market value of $67,500 and a proposed sale date of August 18, 2026.

Rhea-AI Filing Summary

Darling Ingredients Inc. filed a notice of proposed sale of 1,000 shares of Common Stock through Citigroup Global Markets on the NYSE, with an aggregate market value of $67,500 and a proposed sale date of August 18, 2026.

The shares relate to prior employee stock awards granted on January 4, 2022 (270 shares), January 3, 2023 (340 shares), January 4, 2023 (270 shares), and January 3, 2024 (120 shares), all reported as compensation-related common stock.

Key Figures

Shares to be sold: 1,000 shares Aggregate market value: $67,500 Proposed sale date: 08/18/2026 +5 more

8 metrics

Shares to be sold 1,000 shares Common Stock proposed for sale under Form 144

Aggregate market value $67,500 Value of 1,000 shares of Common Stock to be sold

Proposed sale date 08/18/2026 Date of proposed sale of Common Stock on NYSE

2022 employee stock award 270 shares Common Stock granted on 01/04/2022 as compensation

2023 employee stock award (Jan 3) 340 shares Common Stock granted on 01/03/2023 as compensation

2023 employee stock award (Jan 4) 270 shares Common Stock granted on 01/04/2023 as compensation

2024 employee stock award 120 shares Common Stock granted on 01/03/2024 as compensation

Security identifier 157804012 Identifier listed for the Common Stock being sold

Key Terms

Form 144, Employee Stock Award, aggregate market value, Compensation Common Stock

4 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Employee Stock Award financial

"Common Stock | 01/04/2022 | Employee Stock Award | Darling"

aggregate market value financial

"Common Stock | Citigroup Global Markets ... | 1000 | 67500"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Compensation Common Stock financial

"270 | 01/04/2022 | Compensation Common Stock | 01/03/2023"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Darling Ingredients Inc. (DAR) disclose in this Form 144 filing?

Darling Ingredients Inc. discloses a proposed sale of 1,000 shares of its common stock on the NYSE through Citigroup Global Markets, with an aggregate market value of $67,500 and a proposed sale date of August 18, 2026.

How many Darling Ingredients (DAR) shares are proposed to be sold and at what value?

The filing reports an intended sale of 1,000 shares of Darling Ingredients common stock, with an aggregate market value of $67,500. This reflects the value of the restricted or control securities covered by the Form 144 notice.

Which broker and exchange are involved in the DAR Form 144 share sale?

The proposed sale will be executed through Citigroup Global Markets on the NYSE. Citigroup Global Markets is listed as the broker for the transaction involving 1,000 shares of Darling Ingredients common stock.

What is the proposed sale date for the Darling Ingredients (DAR) Form 144 shares?

The proposed sale date for the reported shares is August 18, 2026. This date applies to the sale of 1,000 shares of Darling Ingredients common stock reported in the Form 144 notice.

What employee stock awards underlie the shares in this Darling Ingredients (DAR) Form 144?

The shares relate to prior employee stock awards: 270 shares granted on January 4, 2022, 340 shares on January 3, 2023, 270 shares on January 4, 2023, and 120 shares on January 3, 2024, all classified as compensation common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/18/2026 - 08:16 AM Accepted by SEC EDGAR 08/18/2026 - 08:16 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001845238
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	DARLING INGREDIENTS INC.
SEC File Number	001-13323
Address of Issuer	5601 N. MacArthur Blvd. Irving TEXAS 75038
Phone	972-717-0300
Name of Person for Whose Account the Securities are To Be Sold	Manzi Joseph
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Citigroup Global Markets 390 Greenwich St New York NY 10013	1000	67500	157804012	08/18/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/04/2022	Employee Stock Award	Darling Ingredients Inc.			270	01/04/2022	Compensation
Common Stock	01/03/2023	Employee Stock Award	Darling Ingredients Inc.			340	01/03/2023	Compensation
Common Stock	01/04/2023	Employee Stock Award	Darling Ingredients Inc.			270	01/04/2023	Compensation
Common Stock	01/03/2024	Employee Stock Award	Darling Ingredients Inc.			120	01/03/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Teun Tchornobay, as Attorney-in-Fact for Joseph Manzi
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)